BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

552 related articles for article (PubMed ID: 11748108)

  • 1. Toll-like receptor-4 is expressed by macrophages in murine and human lipid-rich atherosclerotic plaques and upregulated by oxidized LDL.
    Xu XH; Shah PK; Faure E; Equils O; Thomas L; Fishbein MC; Luthringer D; Xu XP; Rajavashisth TB; Yano J; Kaul S; Arditi M
    Circulation; 2001 Dec; 104(25):3103-8. PubMed ID: 11748108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of toll-like receptors in human atherosclerotic lesions: a possible pathway for plaque activation.
    Edfeldt K; Swedenborg J; Hansson GK; Yan ZQ
    Circulation; 2002 Mar; 105(10):1158-61. PubMed ID: 11889007
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibronectin Splicing Variants Containing Extra Domain A Promote Atherosclerosis in Mice Through Toll-Like Receptor 4.
    Doddapattar P; Gandhi C; Prakash P; Dhanesha N; Grumbach IM; Dailey ME; Lentz SR; Chauhan AK
    Arterioscler Thromb Vasc Biol; 2015 Nov; 35(11):2391-400. PubMed ID: 26427793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toll-Like Receptor 9 Plays a Pivotal Role in Angiotensin II-Induced Atherosclerosis.
    Fukuda D; Nishimoto S; Aini K; Tanaka A; Nishiguchi T; Kim-Kaneyama JR; Lei XF; Masuda K; Naruto T; Tanaka K; Higashikuni Y; Hirata Y; Yagi S; Kusunose K; Yamada H; Soeki T; Imoto I; Akasaka T; Shimabukuro M; Sata M
    J Am Heart Assoc; 2019 Apr; 8(7):e010860. PubMed ID: 30905257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of G2A, a receptor for lysophosphatidylcholine, by macrophages in murine, rabbit, and human atherosclerotic plaques.
    Rikitake Y; Hirata K; Yamashita T; Iwai K; Kobayashi S; Itoh H; Ozaki M; Ejiri J; Shiomi M; Inoue N; Kawashima S; Yokoyama M
    Arterioscler Thromb Vasc Biol; 2002 Dec; 22(12):2049-53. PubMed ID: 12482833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of Toll-like receptor 4 or myeloid differentiation factor 88 reduces atherosclerosis and alters plaque phenotype in mice deficient in apolipoprotein E.
    Michelsen KS; Wong MH; Shah PK; Zhang W; Yano J; Doherty TM; Akira S; Rajavashisth TB; Arditi M
    Proc Natl Acad Sci U S A; 2004 Jul; 101(29):10679-84. PubMed ID: 15249654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toll-like receptor 2 stimulation induces intimal hyperplasia and atherosclerotic lesion development.
    Schoneveld AH; Oude Nijhuis MM; van Middelaar B; Laman JD; de Kleijn DP; Pasterkamp G
    Cardiovasc Res; 2005 Apr; 66(1):162-9. PubMed ID: 15769459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Wnt5a is expressed in murine and human atherosclerotic lesions.
    Christman MA; Goetz DJ; Dickerson E; McCall KD; Lewis CJ; Benencia F; Silver MJ; Kohn LD; Malgor R
    Am J Physiol Heart Circ Physiol; 2008 Jun; 294(6):H2864-70. PubMed ID: 18456733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin-Like Growth Factor-1 Receptor Deficiency in Macrophages Accelerates Atherosclerosis and Induces an Unstable Plaque Phenotype in Apolipoprotein E-Deficient Mice.
    Higashi Y; Sukhanov S; Shai SY; Danchuk S; Tang R; Snarski P; Li Z; Lobelle-Rich P; Wang M; Wang D; Yu H; Korthuis R; Delafontaine P
    Circulation; 2016 Jun; 133(23):2263-78. PubMed ID: 27154724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early growth response-1 promotes atherogenesis: mice deficient in early growth response-1 and apolipoprotein E display decreased atherosclerosis and vascular inflammation.
    Harja E; Bucciarelli LG; Lu Y; Stern DM; Zou YS; Schmidt AM; Yan SF
    Circ Res; 2004 Feb; 94(3):333-9. PubMed ID: 14670837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Membrane type 1 matrix metalloproteinase expression in human atherosclerotic plaques: evidence for activation by proinflammatory mediators.
    Rajavashisth TB; Xu XP; Jovinge S; Meisel S; Xu XO; Chai NN; Fishbein MC; Kaul S; Cercek B; Sharifi B; Shah PK
    Circulation; 1999 Jun; 99(24):3103-9. PubMed ID: 10377072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pim-2 kinase inhibits inflammation by suppressing the mTORC1 pathway in atherosclerosis.
    Liao M; Hu F; Qiu Z; Li J; Huang C; Xu Y; Cheng X
    Aging (Albany NY); 2021 Sep; 13(18):22412-22431. PubMed ID: 34547720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of murine embryonic fibroblasts to define Toll-like receptor activation and specificity.
    Kurt-Jones EA; Sandor F; Ortiz Y; Bowen GN; Counter SL; Wang TC; Finberg RW
    J Endotoxin Res; 2004; 10(6):419-24. PubMed ID: 15588425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of SR-PSOX, a novel cell-surface scavenger receptor for phosphatidylserine and oxidized LDL in human atherosclerotic lesions.
    Minami M; Kume N; Shimaoka T; Kataoka H; Hayashida K; Akiyama Y; Nagata I; Ando K; Nobuyoshi M; Hanyuu M; Komeda M; Yonehara S; Kita T
    Arterioscler Thromb Vasc Biol; 2001 Nov; 21(11):1796-800. PubMed ID: 11701468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced stabilization of atherosclerotic plaques in apolipoprotein E-knockout mice by combinatorial Toll-like receptor-1 and -2 gene silencing.
    Qi LH; Wang Y; Gao F; Zhang C; Ding SF; Ni M; Feng JB; Zhang Y
    Hum Gene Ther; 2009 Jul; 20(7):739-50. PubMed ID: 19278303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Upregulation of miR-142-5p in atherosclerotic plaques and regulation of oxidized low-density lipoprotein-induced apoptosis in macrophages.
    Xu R; Bi C; Song J; Wang L; Ge C; Liu X; Zhang M
    Mol Med Rep; 2015 May; 11(5):3229-34. PubMed ID: 25586666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo evidence for a role of toll-like receptor 4 in the development of intimal lesions.
    Vink A; Schoneveld AH; van der Meer JJ; van Middelaar BJ; Sluijter JP; Smeets MB; Quax PH; Lim SK; Borst C; Pasterkamp G; de Kleijn DP
    Circulation; 2002 Oct; 106(15):1985-90. PubMed ID: 12370224
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toll-like receptor 7 stimulation by imiquimod induces macrophage autophagy and inflammation in atherosclerotic plaques.
    De Meyer I; Martinet W; Schrijvers DM; Timmermans JP; Bult H; De Meyer GR
    Basic Res Cardiol; 2012 May; 107(3):269. PubMed ID: 22543675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of toll-like receptor 2 expression by macrophages following Mycobacterium avium infection.
    Wang T; Lafuse WP; Zwilling BS
    J Immunol; 2000 Dec; 165(11):6308-13. PubMed ID: 11086067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interactions of oral pathogens with toll-like receptors: possible role in atherosclerosis.
    Hajishengallis G; Sharma A; Russell MW; Genco RJ
    Ann Periodontol; 2002 Dec; 7(1):72-8. PubMed ID: 16013219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.